The Future of Care or the Automation of Inequality? Part 3
- 4 days ago
- 11 min read
Written by Sajdah Wendy Muhammad, Business Advisor
Wendy is a multi-million-dollar business and real estate developer, global thought leader, crisis manager, emotional intelligence coach, and award-winning urban historic preservationist. An international entrepreneur, she has pioneered innovative healthcare business models and founded the Mind of an Entrepreneur® brand to empower marginalized communities through wealth-building, business ownership, and sustainable community development.
Artificial intelligence will influence not only patients but also healthcare workers, healthcare entrepreneurs, clinic owners, physicians, nurses, coders, billers, administrators, and allied health professionals. For Black healthcare professionals, the question is not simply whether AI will make work easier. The question is whether AI will become a tool of professional expansion or another layer of surveillance, liability, displacement, and exclusion.
The existing problem: Documentation burden and lost clinical capacity
Modern healthcare professionals practice inside systems that require extensive documentation for clinical care, reimbursement, compliance, quality reporting, malpractice defense, and regulatory review. This burden can be substantial. The American Medical Association reported that 43.2 percent of physicians experienced at least one symptom of burnout in 2024. Administrative burden and after-hours electronic health record work remain major contributors.
For nurses, documentation burden is also significant. The American Association of Critical-Care Nurses cites the U.S. Surgeon General's advisory, indicating that nurses spend, on average, about 40 percent of a shift performing documentation, reducing time available for direct patient care.
This means documentation is clinical capacity. Every hour spent charting is an hour not spent examining patients, educating families, coordinating care, identifying risks, or building the patient-provider relationship.
Administrative relief and patient-care expansion
AI-assisted charting, clinical summaries, scheduling, coding support, prior authorization assistance, referral tracking, and patient follow-up systems may significantly reduce the administrative pressure placed on healthcare professionals. For a sole practitioner, this is especially important. A small medical practice does not have the administrative infrastructure of a hospital system. One physician, nurse practitioner, therapist, dentist, or specialist may be carrying the burden of clinical care, documentation, billing oversight, compliance, staffing, patient communication, and business operations.
If AI reduces charting time, improves documentation completeness, flags missing information, drafts referral letters, tracks follow-up, and supports billing accuracy, a sole practitioner may be able to serve more patients safely, reduce appointment backlogs, improve follow-up compliance, spend more time in direct patient care, reduce after-hours work, improve billing accuracy, reduce claim denials, strengthen malpractice documentation, and improve regulatory readiness.
This may be especially meaningful for Black healthcare entrepreneurs operating small clinics, wellness centers, behavioral health practices, specialty practices, and community-based care models. AI can become a true capacity multiplier.
Workforce displacement risk
The opportunity is real, but so is the disruption. Certain healthcare functions may become partially automated, including medical coding, scheduling, billing functions, patient intake, claims follow-up, prior authorization support, diagnostic support roles, administrative coordination, and documentation review.
This may reduce costs for institutions, but it may also disrupt workers concentrated in lower-paid administrative and support roles. For Black healthcare workers, who are often overrepresented in frontline and support positions, policy must distinguish between automation that upgrades workers and automation that displaces them. Is the objective workforce transition or workforce erasure?
Liability, malpractice, and regulatory exposure
AI also creates a new risk environment. Healthcare professionals may face liability if they rely too heavily on AI outputs, fail to review AI-generated documentation, overlook incorrect recommendations, or cannot explain how an AI-supported clinical decision was made. This is especially important because diagnostic errors remain a major source of malpractice claims. Medical liability literature identifies wrong diagnosis, delayed diagnosis, and missed diagnosis as leading malpractice allegations, and documentation problems frequently contribute to these claims.
AI may improve documentation, but it may also create new vulnerabilities.
For example, an AI-generated note may contain inaccurate statements, a clinical decision tool may recommend an inappropriate pathway, a risk score may underestimate a patient's condition, a billing algorithm may support coding that later appears improper, a prior authorization tool may omit relevant clinical facts, or a provider may be unable to explain an AI-supported decision during review.
For entrepreneurial healthcare professionals, these risks are especially serious. Small practices often have fewer legal, compliance, and technology resources than large hospital systems. If AI tools produce flawed documentation or inaccurate recommendations, small providers may carry the consequences through malpractice claims, payer audits, licensing reviews, billing disputes, or regulatory investigations. AI therefore must be governed not only as a clinical tool but also as a compliance and liability tool.
Representation in AI development
A more fundamental question concerns ownership and influence. Who builds healthcare AI? Who trains it? Who validates it? Who profits from it? Who bears liability when it fails?
Without increased participation of Black physicians, nurses, engineers, researchers, entrepreneurs, healthcare administrators, compliance professionals, and clinic owners within AI development ecosystems, future healthcare infrastructure may be shaped without sufficient representation.
This is not only a diversity issue. It is a quality-control issue.
Healthcare AI designed without the insight of professionals serving marginalized communities may miss the operational realities of those communities, including underinsurance, transportation barriers, chronic disease burden, delayed presentation, mistrust, staffing shortages, and small-practice economics.
Policy implication
AI should not be used merely to reduce labor costs. It should be used to expand clinical capacity, improve patient care, protect healthcare workers, strengthen small practices, and create ownership opportunities within the communities most affected by healthcare disparities.
For Black healthcare professionals, AI must become a bridge to capacity, capital, protection, and participation, not a pathway to displacement.
The economic question, "Who owns healthcare AI?"
Artificial intelligence represents more than a clinical transformation. It represents a restructuring of healthcare infrastructure itself.
For decades, healthcare institutions have competed through physical assets, provider networks, insurance relationships, and clinical expertise. Increasingly, however, competitive advantage may be determined by something different, control over data, algorithms, computational infrastructure, and the systems that transform information into clinical decision making.
Artificial intelligence increasingly influences who receives care, when care is delivered, how risk is measured, which interventions are recommended, how reimbursement occurs, how labor is allocated, and, ultimately, who captures economic value within healthcare systems. This creates a more fundamental policy question.
As healthcare becomes increasingly dependent upon artificial intelligence, who owns and controls the systems making these decisions? The answer is not simple.
The ownership problem
Healthcare AI does not operate within a simple ownership structure. Multiple stakeholders may simultaneously control different components of the system. Hospitals and physician practices frequently generate clinical data. Software companies may develop algorithms. Cloud infrastructure companies may host computational systems. Third-party vendors may train models. Insurance companies may influence reimbursement pathways. Regulators may determine acceptable use. Patients generate enormous quantities of data but frequently possess limited control over how that information is monetized or deployed. This creates a fundamental governance question.
Who actually owns healthcare intelligence?
As a result, healthcare artificial intelligence operates within fragmented ownership structures where control, liability, financial benefit, and decision-making authority may reside in different places simultaneously. The economic implications are substantial. Ownership determines not only who profits from healthcare AI. Ownership increasingly determines who controls future healthcare itself.
Why ownership matters
Ownership determines more than profits. Ownership determines who controls decision-making frameworks, who controls updates and modifications, who determines risk thresholds, who controls pricing structures, who captures financial returns, who controls access, and who bears responsibility when systems fail.
Consider a simple example. A physician may rely upon an AI-assisted diagnostic tool. The hospital may license the software. A technology company may own the algorithm. A third party may train the model. Cloud infrastructure may be operated elsewhere.
If a patient experiences harm, who carries responsibility? The physician? The hospital? The software company? The data provider? The vendor? Ownership questions quickly become liability questions.
Data ownership and economic extraction
Healthcare AI systems require enormous quantities of data. This data frequently originates from clinical encounters, imaging studies, laboratory testing, wearable devices, insurance claims, electronic medical records, pharmacy records, and remote monitoring systems.
Communities generate enormous amounts of healthcare data every day, often without recognizing the scale of economic value embedded within that information. Every physician visit, laboratory result, prescription, imaging study, insurance claim, wearable device measurement, hospitalization, and remote monitoring interaction contributes to a growing digital ecosystem that increasingly powers artificial intelligence systems. As healthcare becomes more dependent upon AI, a more profound question emerges, "Who ultimately controls the information generated from human illness, treatment, recovery, and survival?"
Historically underserved communities may find themselves positioned at the center of this question.
Healthcare data no longer functions solely as a clinical record. It increasingly functions as an economic asset.
The same information used to diagnose disease and coordinate treatment may also contribute to pharmaceutical research, predictive analytics systems, medical device development, insurance products, venture-backed technologies, population health platforms, and future generations of healthcare artificial intelligence. This creates a complicated reality.
Patients may enter healthcare systems seeking treatment while simultaneously contributing information that may later support commercial products, new technologies, market expansion strategies, or profitable intellectual property ecosystems. Many patients may never fully understand how information moves through increasingly interconnected healthcare systems.
Data may move between hospitals, technology vendors, cloud infrastructure providers, research organizations, insurance companies, pharmaceutical firms, and third-party software platforms operating within complex contractual relationships that are often invisible to the individuals generating the information itself. The concern, therefore, extends beyond privacy. The concern is control, influence, and the risk of misuse.
Who determines acceptable uses of health information once collected? Who governs commercialization? Who bears responsibility when data is misused, improperly shared, reidentified, or deployed in ways patients never anticipated?
Healthcare AI, therefore, creates a debate much larger than technology. It introduces questions surrounding data sovereignty, economic participation, consent, ownership, governance, and power. The future healthcare economy may increasingly belong not simply to those who deliver care, but to those who control the information from which future care is built.
Market concentration risk
Healthcare already exhibits substantial consolidation. Over recent decades, hospitals, physician groups, insurers, pharmacy systems, and healthcare service providers have increasingly merged, acquired competitors, expanded vertically, and concentrated market power. Artificial intelligence may accelerate this trend. Unlike many traditional healthcare technologies, AI systems frequently require significant investments in infrastructure, including data acquisition, cloud computing resources, cybersecurity protections, regulatory compliance systems, specialized technical talent, legal oversight, implementation support, and continuous algorithm maintenance.
Large healthcare organizations frequently possess advantages, including larger datasets, greater access to capital, stronger legal teams, specialized personnel, greater negotiating power, and substantially larger technology budgets. Smaller physician practices, independent clinics, community-based providers, rural healthcare organizations, and entrepreneurial healthcare professionals may face greater barriers to adoption. This creates an important policy concern. Artificial intelligence may not simply improve healthcare delivery. It may alter competitive dynamics within healthcare markets.
If large institutions possess disproportionate access to AI infrastructure, they may increasingly benefit from lower operating costs, larger patient volumes, greater pricing leverage, stronger negotiating power with insurers, better data acquisition capabilities, and faster innovation cycles.
This creates a self-reinforcing cycle. Larger organizations may generate more patients. More patients create larger datasets. Larger datasets improve algorithms. Improved algorithms attract additional patients. Additional patients create additional revenue. Additional revenue increases technological advantage. Over time, these feedback loops may create increasingly concentrated markets.
This raises important antitrust questions.
Could artificial intelligence unintentionally create barriers to entry for new healthcare entrepreneurs?
Could proprietary algorithms function similarly to exclusive infrastructure that competitors cannot realistically access?
Could control over datasets create market advantages that are difficult for smaller competitors to overcome?
Could algorithm ownership eventually influence referral patterns, reimbursement structures, pricing power, or patient access?
Healthcare consolidation may unfairly influence patient choice, pricing power, innovation rates, provider independence, local healthcare access, community-based care models, and labor markets for healthcare workers.
Historically, antitrust policy has focused primarily on physical assets, pricing behavior, and market share. Artificial intelligence introduces new questions. Should regulators evaluate ownership of healthcare data similarly to other forms of critical infrastructure? Should algorithmic dominance create additional regulatory scrutiny? Should healthcare AI markets include interoperability requirements to prevent technological lock-in? The policy question, therefore, is not whether healthcare organizations should innovate. The policy question is whether artificial intelligence will create more competitive healthcare markets or increasingly concentrated ones.
This could be the death of healthcare entrepreneurs
The debate cannot focus solely upon AI consumption. It must also consider the impact on healthcare entrepreneurs, ownership opportunities, healthcare entrepreneurship, workforce pipelines, procurement participation, research participation, venture capital access, intellectual property creation, and technology licensing opportunities.
The communities building healthcare infrastructure may ultimately determine how future healthcare systems operate. Artificial intelligence may reshape healthcare. The more important question is who will own the future healthcare system it creates.
Policy recommendations: Building equitable healthcare AI infrastructure
Artificial intelligence governance cannot rely exclusively upon innovation incentives and market adoption. Healthcare represents critical political and economic infrastructure. Decisions produced by healthcare algorithms increasingly influence diagnosis, treatment pathways, insurance approvals, workforce deployment, and resource allocation. As artificial intelligence becomes more deeply integrated into clinical decision-making, policymakers must shift from reactive oversight toward intentional infrastructure design.
The following policy interventions should be considered foundational rather than optional.
1. Mandatory algorithmic auditing and equity impact assessments
Healthcare institutions regularly evaluate medications, devices, procedures, and financial systems for performance. AI systems should face similar scrutiny.
Prior to deployment, healthcare algorithms should undergo mandatory independent evaluation examining performance across demographic groups, false positive and false negative rates, outcome disparities by race, geography, income, gender, and age, unintended downstream consequences, and financial impacts associated with algorithmic decisions.
Equity impact assessments should become standard operating procedure before implementation.
If an AI triage system incorrectly deprioritizes high-risk patients, delays in care may disproportionately affect communities already experiencing elevated rates of chronic illness. If predictive systems allocate fewer resources to historically underserved populations because previous spending was lower, existing inequities become mathematically reinforced. Federal and state regulators could require periodic algorithmic recertification similar to existing clinical quality reviews. Healthcare systems deploying AI without demonstrating equitable performance may assume increased regulatory liability. Correcting algorithmic inequities after large-scale deployment becomes substantially more expensive than preventing them during design.
2. Diverse data standards and representative training requirements
Artificial intelligence quality depends heavily upon training data. Historically, many datasets have suffered from underrepresentation of minority populations, unequal access patterns reflected within data collection, geographic concentration, inconsistent demographic reporting, and insufficient participation within clinical trials.
Policymakers should consider minimum representation thresholds, expanded research participation incentives, demographic disclosure requirements, and national repositories supporting diverse datasets.
Representative datasets should be viewed as infrastructure investments rather than compliance exercises.
3. Transparency requirements and explainable AI standards
Healthcare requires explainability because clinical decisions affect life outcomes. Policy interventions should include mandatory disclosure when AI materially influences care, documentation requirements explaining decision logic, patient access rights regarding algorithmic decision-making, and institutional governance committees reviewing implementation.
Transparency does not require revealing proprietary code. Transparency requires accountability. Trust functions as infrastructure.
4. Healthcare workforce transition strategies
Healthcare systems should proactively develop transition strategies, including AI literacy education, retraining pathways, workforce grants, continuing education incentives, and educational partnerships.
The objective should not simply be workforce replacement. The objective should be workforce augmentation.
5. Procurement reform and economic participation requirements
Policy interventions may include supplier diversity requirements, minority participation goals, expanded venture capital access, innovation districts, and healthcare technology incubators.
AI deployment without economic participation risks widening existing wealth gaps. Ownership drives long-term wealth accumulation.
6. Community governance models for healthcare AI
Community governance models may include patient advisory boards, public review panels, community benefit agreements, hospital-community technology councils, and participatory decision-making processes.
Healthcare infrastructure functions within social systems rather than purely technical systems.
Conclusion: From regulation to infrastructure design
The healthcare AI conversation should move beyond questions of whether artificial intelligence should be adopted. The more important question concerns how institutions intentionally design systems capable of producing equitable outcomes. Artificial intelligence itself is neither inherently equitable nor inherently discriminatory. It reflects the systems from which it learns. Healthcare AI is not simply software. It is emerging infrastructure. Infrastructure decisions shape societies for generations. Technology can scale solutions. It can also scale inequities. The decisions made today will determine which future emerges.
Read more from Sajdah Wendy Muhammad
Sajdah Wendy Muhammad, Business Advisor
Wendy Muhammad is a multi-million-dollar business developer, Author of the best-selling book, The Art and Science of Business, an Award-Winning Urban Historic Preservationist and Real Estate Developer, with more than $500 million in projects across healthcare, real estate, infrastructure, and community development. Muhammad is a leading voice in empowering entrepreneurs and building generational wealth. Her Mind of an Entrepreneur brand includes podcasts, workshops, and books that blend strategy, spirituality, and economic empowerment.
.jpg)
